We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Investigating Splicing Efficiency in HRAS to Control Costello Syndrome Phenotype and Frequency in Cancer

Article   Jul 06, 2016

 
Investigating Splicing Efficiency in HRAS to Control Costello Syndrome Phenotype and Frequency in Cancer
 
 
Advertisement
 

RELATED ARTICLES

The Coronavirus Outbreak

Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

READ MORE

Building Better Cell Lines

Article

Scientists have access to several approaches for developing cell lines. Whilst some tried and true methods have fallen by the wayside with the adoption of newer technologies, many older protocols are still in use alongside next-generation methods.

READ MORE

Silencing the SARS-CoV-2 Receptor With CRISPR and Epigenetic Modifications

Article

What happens when you transiently turn "off" the gene that encodes ACE2, the protein that is required for SARS-CoV-2 to enter and infect cells? This is what Jamie Hackett and colleagues are currently exploring in animal models, to determine whether epigenetic silencing could be a treatment approach for COVID-19 in humans.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE